// App-Quantinova.ai

e20086 : Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment.

Researchers

Presenter

  • Ippokratis Messaritakis

Principal Investigators

  • Michail Nikolaou

  • Filippos Koinis

  • Eleni Politaki

  • Anastasios Koutsopoulos

  • Eleni Lagoudaki

  • Vassilis Georgoulias

  • Athanasios Kotsakis

Medical Centers

  • Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Heraklion, Greece

  • Department of Internal Medicine, Medical Oncology Unit, Elena Venizelou General Maternal Hospital of Athens, Athens, Greece

  • Department of Medical Oncology, University General Hospital of Heraklion, Athens, Greece

  • Laboratory of Pathology, University General Hospital of Heraklion, Heraklion, Greece

  • First Department of Medical Oncology, Metropolitan General Hospital of Athens, Athens, Greece

Locations

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

Drug/Treatment

  • Etoposide

  • Etoposide phosphate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved